Hattori Y, Kasai K, So S, Hattori S, Banba N, Shimoda S
Department of Endocrinology, Dokkyo University School of Medicine, Tochigi, Japan.
Life Sci. 1995;57(20):1833-40. doi: 10.1016/0024-3205(95)02163-d.
We investigated whether calcium channel antagonists would alter the induction of nitric oxide (NO) synthesis by bacterial lipopolysaccharide (LPS) alone or in combination with interferon-gamma (IFN gamma) in cultured J774 macrophages, rat vascular smooth muscle cells, rat renal mesangial cells, and rat cardiac myocytes. The induction of NO synthesis was determined by measuring nitrite, the stable end-product. The dihydropyridine calcium channel antagonists, nifedipine, manidipine, nitrendipine, benidipine, barnidipine, perdipine, and nilvadipine all reduced the LPS-induced nitrite production in a dose-dependent manner, each with a differing half-maximal inhibitory concentration, in cultured J774 macrophages. Nifedipine also inhibited nitrite production in vascular smooth muscle cells, mesangial cells, and cardiac myocytes. The half-maximal inhibitory concentrations of nifedipine were ranked as follows: smooth muscle cells < mesangial cells < cardiac myocytes. Diltiazem, at nontoxic concentrations, had no effect on the nitrite formation in the three cell types. Verapamil markedly increased the formation of nitrite in cardiac myocytes in response to LPS and IFN gamma, but not in vascular smooth muscle or mesangial cells. Exposure of cardiac myocytes to LPS and IFN gamma caused the expression of NO synthase mRNA that was significantly increased by verapamil. Thus, certain calcium channel antagonists modulate NO synthesis by altering the induction of NO synthase.
我们研究了钙通道拮抗剂是否会改变细菌脂多糖(LPS)单独或与干扰素-γ(IFNγ)联合在培养的J774巨噬细胞、大鼠血管平滑肌细胞、大鼠肾系膜细胞和大鼠心肌细胞中诱导一氧化氮(NO)合成的情况。通过测量亚硝酸盐(稳定的终产物)来确定NO合成的诱导情况。二氢吡啶类钙通道拮抗剂硝苯地平、马尼地平、尼群地平、贝尼地平、巴尼地平、培地平及尼伐地平均以剂量依赖方式降低培养的J774巨噬细胞中LPS诱导的亚硝酸盐生成,每种药物的半数最大抑制浓度不同。硝苯地平也抑制血管平滑肌细胞、系膜细胞和心肌细胞中的亚硝酸盐生成。硝苯地平的半数最大抑制浓度排序如下:平滑肌细胞<系膜细胞<心肌细胞。地尔硫䓬在无毒浓度下对三种细胞类型中的亚硝酸盐形成无影响。维拉帕米显著增加心肌细胞中LPS和IFNγ刺激下的亚硝酸盐生成,但对血管平滑肌或系膜细胞无此作用。心肌细胞暴露于LPS和IFNγ会导致NO合酶mRNA表达,维拉帕米可使其显著增加。因此,某些钙通道拮抗剂通过改变NO合酶的诱导来调节NO合成。